These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 1516722)
1. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]. Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722 [TBL] [Abstract][Full Text] [Related]
2. A case report of pseudohypoparathyroidism (Drezner's type I) associated with probable Bartter's syndrome. Iba K; Morii H; Wada M; Yasumoto R; Kishimoto T; Mitsuhashi T; Hojo K; Okahara T Endocrinol Jpn; 1981 Oct; 28(5):595-604. PubMed ID: 7047153 [TBL] [Abstract][Full Text] [Related]
3. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone. Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)]. Yamada K; Tamura Y; Yamamoto M; Kumagai A Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053 [TBL] [Abstract][Full Text] [Related]
5. [A case of pseudo-Bartter's syndrome associated with hypokalemic myopathy]. Imai T; Izai M; Narimiya S; Nagaki M; Adachi T; Oohira T; Kamikubo K; Shiooka M; Fujioka H; Kotoo Y Nihon Naibunpi Gakkai Zasshi; 1988 Jul; 64(7):582-92. PubMed ID: 3220155 [TBL] [Abstract][Full Text] [Related]
6. Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome. Sann L; David L; Bernheim J; François R Helv Paediatr Acta; 1978 Aug; 33(3):299-310. PubMed ID: 711493 [TBL] [Abstract][Full Text] [Related]
7. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629 [TBL] [Abstract][Full Text] [Related]
8. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects]. Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236 [TBL] [Abstract][Full Text] [Related]
9. Association of Bartter's syndrome and empty sella. Ertekin V; Selimoglu AM; Orbak Z J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1065-8. PubMed ID: 14513887 [TBL] [Abstract][Full Text] [Related]
10. Asymptomatic Bartter's syndrome. Barbour GL; Day JO South Med J; 1978 Nov; 71(11):1341-4, 1349. PubMed ID: 715482 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II. Seki T; Yamamoto M; Kimura H; Tsuiki M; Ono M; Miki N; Takano K; Sato K Endocr J; 2010; 57(8):735-44. PubMed ID: 20505259 [TBL] [Abstract][Full Text] [Related]
12. [Development of tetany in siblings suffered from Bartter's syndrome]. Suitsu N; Kita S; Okamoto S; Kimura S; Shiozaki Y No To Shinkei; 1984 Aug; 36(8):749-54. PubMed ID: 6498022 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of a girl with the neonatal form of Bartter's syndrome. Nakagawa Y; Toya K; Natsume H; Nasuda K; Takeuchi H; Kubota A; Ogawa H; Igarashi Y Endocr J; 1997 Apr; 44(2):275-81. PubMed ID: 9228463 [TBL] [Abstract][Full Text] [Related]
14. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism]. Inoue D Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624 [TBL] [Abstract][Full Text] [Related]
16. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3. Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630 [TBL] [Abstract][Full Text] [Related]
17. [A case with Bartter's syndrome associated with type II hyperlipidemia, increased fluidity of plasma VLDL and abnormal configuration of peripheral erythrocytes (author's transl)]. Imai T; Makino K; Takeda N; Nakamura S; Endo Y; Okuyama M; Miura K; Iida H; Kawade M Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):131-47. PubMed ID: 7044842 [TBL] [Abstract][Full Text] [Related]
18. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia]. Iida S Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I. Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982 [TBL] [Abstract][Full Text] [Related]
20. The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism. Stone MD; Hosking DJ; Garcia-Himmelstine C; White DA; Rosenblum D; Worth HG Bone; 1993; 14(5):727-35. PubMed ID: 8268047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]